Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study
Pal et al., Frontiers in Medicine, doi:10.3389/fmed.2020.590805
Pal et al., High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study, Frontiers in Medicine, doi:10.3389/fmed.2020.590805
Jan 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 72 non-severe COVID-19 patients in India, showing very high levels of vitamin D deficiency (70 of 72 patients).
Pal et al., 7 Jan 2021, peer-reviewed, 11 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: BRIEF RESEARCH REPORT published: 07 January 2021 doi: 10.3389/fmed.2020.590805 High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study Rimesh Pal 1 , Sant Ram 2*, Deepy Zohmangaihi 2 , Indranil Biswas 3 , Vikas Suri 4 , Laxmi N. Yaddanapudi 3 , Pankaj Malhotra 4 , Shiv L. Soni 3 , Goverdhan D. Puri 3 , Ashish Bhalla 4 and Sanjay K. Bhadada 1* 1 Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India, 2 Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh, India, 3 Department of Anesthesiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India, 4 Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India Edited by: Giacomina Brunetti, University of Bari Aldo Moro, Italy Reviewed by: Luigi Gennari, University of Siena, Italy Sudhaker D. Rao, Henry Ford Hospital, United States *Correspondence: Sanjay K. Bhadada bhadadask@rediffmail.com Sant Ram drsantram2016@gmail.com Specialty section: This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine Received: 03 August 2020 Accepted: 09 December 2020 Published: 07 January 2021 Citation: Pal R, Ram S, Zohmangaihi D, Biswas I, Suri V, Yaddanapudi LN, Malhotra P, Soni SL, Puri GD, Bhalla A and Bhadada SK (2021) High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study. Front. Med. 7:590805. doi: 10.3389/fmed.2020.590805 Frontiers in Medicine | www.frontiersin.org Purpose: To compare serum total calcium and phosphate levels in patients with non-severe COVID-19 with age, sex, and serum 25-hydroxyvitamin D level matched healthy adult cohort. Methods: In this retrospective case-control study, medical records of patients (≥18 years) diagnosed as non-severe COVID-19 admitted at and discharged from our tertiary care institution during the period from April 10, 2020 and June 20, 2020 were retrieved. Baseline investigations, notably, serum calcium, phosphate, albumin, magnesium, 25-hydroxyvitamin D, and C-reactive protein (CRP), were performed at admission before any form of calcium or vitamin D supplementation were considered. The biochemical parameters were compared with age, sex, and 25-hydroxyvitamin D matched healthy adult controls (1:1 ratio) derived from the Chandigarh Urban Bone Epidemiological Study (CUBES). Results: After exclusion, 72 patients with non-severe COVID-19 (63 mild and 9 moderate disease) and an equal number of healthy controls were included in the final analysis. Age, sex, serum 25-hydroxyvitamin D, and albumin levels were matched between the 2 groups. Hypovitaminosis D and hypocalcemia were seen in 97 and 67% of the patients, respectively. The patients had lower serum calcium (P value <0.001) and phosphate (P = 0.007) compared with the controls. There was no statistically significant correlation between serum calcium and CRP. Conclusions: Hypocalcemia is highly prevalent even in COVID-19 patients with non-severe disease probably implying that hypocalcemia is intrinsic to the disease. Prospective studies with larger number of patients are required to prove this hypothesis and unravel the underlying pathophysiological mechanisms. Keywords: COVID-19, calcium, hypocalcemia, hypovitaminosis D, vitamin D 1 January 2021 | Volume 7 | Article..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit